Rocket Pharmaceuticals
RCKT
RCKT
56 hedge funds and large institutions have $558M invested in Rocket Pharmaceuticals in 2018 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 14 increasing their positions, 2 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
67.52% more ownership
Funds ownership: 11.01% → 78.53% (+68%)
65% more funds holding
Funds holding: 34 → 56 (+22)
Holders
56
Holding in Top 10
3
Calls
$825K
Puts
$223K
Top Buyers
| 1 | +$258M | |
| 2 | +$55.6M | |
| 3 | +$32.2M | |
| 4 |
BM
Bridger Management
New York
|
+$29.6M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$28.5M |
Top Sellers
| 1 | -$4.7M | |
| 2 | -$3.57M | |
| 3 | -$1.66M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.4M |
| 5 |
JPMorgan Chase & Co
New York
|
-$147K |